Loading…
← CockpitCompetitor Analysis › 600623.SS Shanghai Huayi Group Corporation Ltd. Class AOpen in the cockpit ↗

Shanghai Huayi Group Corporation Ltd. Class A600623.SSCompetitor analysis, valuation and peers

China · CNY·Materials›Chemicals: Specialty

Shanghai state-owned diversified chemical group spanning chlor-alkali chemicals, dyes/pigments, agrochemicals and new materials.

Momentum neutral 57
Mkt cap
$2.41B
US dollars, full cap
Free float
33%
of shares outstanding
$/day
$20.9M
20-day average traded
Fwd P/E
14.8×
forward earnings
ROIC−WACC
n/a
WACC 5.0%
Hurdle
-21 pp
Req g minus delivered
Next earnings
172 days
27 Apr 2027
Close · CNYCN¥8.22
1D-1.1%
1W+4.3%
1M-5.4%
3M-1.9%
6M-24.4%
YTD+6.6%
1Y+4.5%
ATR %3.4%
52w lowhigh33.0% off high

What Shanghai Huayi does

Shanghai state-owned diversified chemical group spanning chlor-alkali chemicals, dyes/pigments, agrochemicals and new materials.

Products and services

  • Chlor-alkali chemicals (caustic soda, PVC)
  • Dyes/pigments
  • Agrochemicals
  • New materials

Customers

  • Textile/dye industry
  • Plastics/PVC manufacturers
  • Agrochemical distributors

Where it sits in the supply chain

  • Materials
  • Diversified chemicals

What could go wrong

  • Commodity chemical price cycles
  • Conglomerate complexity

Moat: none (scale). Diversified state-owned commodity-chemical conglomerate without a single strong product moat.

Headquarters: Shanghai, China · Employees: 13,144

Named competitors

Shanghai Huayi at a glance

Size Shanghai Huayi (600623.SS) is a China Materials company (Chemicals: Specialty) with a market value of $2.41B, the 1070th largest of 4,839 China companies the cockpit tracks. Shares closed at CN¥8.22 on 6 Nov 2026.

Performance Over six months the shares fell 24.4%, against -12.2% for the median peer and -16.4% for the China market (cap-weighted) — 4th lowest of 21 in its peer set.

Growth Revenue grew 5.1% over the last twelve months (peer median +7.4%).

Valuation It trades at 14.8× forward earnings against a peer median of 16.2× (8th cheapest of 17).

Price implies For today's price to make sense, revenue must grow about -11% a year for seven years (Req g). Recent delivered growth is +10%, so the hurdle is -21 pp: the price already allows for a slowdown.

Next results Next results expected around 27 Apr 2027 (exchange calendar; dates can move).

Relative performance

8010011 May 202611 Aug 20266 Nov 2026Peer median 87600623.SS 75
Six months, rebased to 100: Shanghai Huayi against the median of its 20 peers (local-currency closes).

Shanghai Huayi financials

Reported figures in CNY; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
RevenueCN¥48.9BCN¥46.4BCN¥49.6BCN¥41.2BCN¥38.9B
Revenue growth—-7%+20%+6%—
Gross profitn/aCN¥3.71BCN¥4.28BCN¥3.62BCN¥3.58B
EBITDAn/aCN¥2.74BCN¥3.68BCN¥2.43BCN¥2.45B
Net incomeCN¥806MCN¥555MCN¥1.06BCN¥861MCN¥1.28B
Free cash flowCN¥4.28B-CN¥3.15B-CN¥436MCN¥1.44BCN¥909M
Capital expenditureCN¥2.89BCN¥3.29BCN¥4.41BCN¥2.88BCN¥5.08B
Total debtCN¥32.5BCN¥23.9BCN¥25.9BCN¥25.5BCN¥23.0B

Quarterly statements and history in the cockpit →

Shanghai Huayi competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-40%-20%0%+20%-40%-20%0%30082142026883634118KEMIRA600500603067KWR002145600339DEEPAKNTR7988603002002895ROG605020011790PIIND600623.SS6-month return →1-month return →
Up and to the right = strong over both horizons. Shanghai Huayi is the large dot.

Fundamentals: revenue growth against valuation

-25%0%+25%+50%+75%20×40×60×42026883634118KEMIRA603067KWR600339DEEPAKNTR603002002895ROG605020601568PIIND600623.SSRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Shanghai Huayi is the large dot.

Capital: growth delivered against growth the price implies

0%+20%0%20%30082142026883634118KEMIRA600500KWR7988002895ROG600623.SSGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Shanghai Huayi is the large dot.

Shanghai Huayi competitors and peer comparison

Head to head with its named competitors (600623.SS vs 600309.SS vs 600141.SS vs 002092.SZ)
CompanyMarket cap6M returnRevenue growthOp. marginForward P/EReq g
Shanghai Huayi 600623.SS$2.41B-24%+5%n/a14.8×-11.1%
Wanhua Chemical 600309.SS$34.1B-19%+37%11%11.3×-2.6%
Hubei Xingfa Chemicals 600141.SS$4.19B-27%+4%8%15.3×n/a
Xinjiang Zhongtai Chemical 002092.SZ$1.57B-41%+7%3%25.4×-4.2%
Xinjiang Tianye 600075.SS$1.04B-41%-10%-3%n/an/a
Tangshan Sanyou Chemical Industries 600409.SS$1.72B-28%+1%1%24.0×4.5%

How Shanghai Huayi compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Shanghai Huayi against its 20 peers (data as of 6 Nov 2026)
Measure600623.SSPeer medianRank in peer set
1-month return-5.4%-5.7%9th highest of 21
6-month return-24.4%-12.2%4th lowest of 21
Distance from 52-week high-33.0%-35.0%10th highest of 21
Revenue growth (TTM)+5.1%+7.4%9th lowest of 21
Forward P/E14.8×16.2×8th cheapest of 17
Growth the price implies (Req g, 7 yrs)-11.1%10.3%least demanding of 12
Growth delivered (Del g)+10.3%+6.6%2nd highest of 12
Hurdle (Req g minus delivered)-21.5 pp+10.1 pp2nd least demanding of 12

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Shanghai Huayi 600623.SSChina$2.41B-24%+5%n/a14.8×-11.1%+10.3%
Shandong Dongyue Silicone Material 300821.SZChina$2.43B-11%+13%13%n/a20.7%+8.6%
Daicel 4202.TJapan$2.48B+24%+2%7%11.1×6.1%+8.1%
Bloomage Biotechnology 688363.SSChina$2.49B-16%-22%5%55.6×20.8%+9.8%
Kaneka 4118.TJapan$2.30B+23%+4%5%11.6×4.9%+7.0%
Kemira KEMIRA.HEFinland$2.55B-8%-3%8%16.0×3.9%+2.6%
Sinochem International 600500.SSChina$2.27B-7%-5%-1%n/a11.9%-2.7%
Hubei Zhenhua Chemical 603067.SSChina$2.56B-35%+31%11%23.6×n/an/a
Quaker Houghton KWRUnited States$2.58B+2%+9%9%16.9×16.3%+5.9%
Tinergy Chemical 002145.SZChina$2.23B-15%+17%9%n/an/an/a
China Petroleum Engineering 600339.SSChina$2.60B-24%+8%1%26.7×n/an/a
Deepak Nitrite DEEPAKNTR.NSIndia$2.22B-17%+25%14%16.5×n/an/a
Nifco 7988.TJapan$2.62B+6%+4%14%11.7×-3.5%+6.6%
Epoxy Base Electronic Material 603002.SSChina$2.19B-7%+73%7%71.6×n/an/a
Guizhou Chanhen Chemical 002895.SZChina$2.64B-20%+15%18%12.9×2.4%+36.1%
Rogers ROGUnited States$2.17B-13%+7%10%26.2×10.3%+0.2%
Zhejiang Yonghe Refrigerant 605020.SSChina$2.17B+5%+25%18%13.3×n/an/a
K+s SDF.DEGermany$2.68B-13%+6%34%11.7×n/an/a
SKC 011790.KSSouth Korea$2.14B-46%+24%-9%n/an/an/a
Shaanxi Beiyuan Chemical Industry 601568.SSChina$2.11B-9%-8%-4%11.8×11.8%-1.8%
PI Industries PIIND.NSIndia$2.79B-44%-15%13%22.7×n/an/a

Questions

Who are Shanghai Huayi's main competitors?
Named competitors: Wanhua Chemical Group (600309.SS), Hubei Xingfa Chemicals Group (600141.SS), Xinjiang Zhongtai Chemical (002092.SZ), Xinjiang Tianye (600075.SS), Tangshan Sanyou Chemical Industries (600409.SS). The cockpit's measured peer set (industry) also includes Shandong Dongyue Silicone Material (300821.SZ), Daicel (4202.T), Bloomage Biotechnology (688363.SS), Kaneka (4118.T), Kemira (KEMIRA.HE), Sinochem International (600500.SS).
Is Shanghai Huayi expensive compared with its peers?
On forward p/e it trades at 14.8× against a peer median of 16.2×, 8th cheapest of 17 in its peer set. For today's price to make sense, revenue must grow about -11% a year for seven years (Req g). Recent delivered growth is +10%, so the hurdle is -21 pp: the price already allows for a slowdown.
How has Shanghai Huayi stock performed?
Over six months to 6 Nov 2026 the shares returned -24.4% against -12.2% for the median peer; over one year +4.5%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.